HAVCR2 and chordoma: CD47, SIRPα, and TIM3 are all expressed on TAMs, and chordoma CD47 expression shows the highest degree of expression among various sarcomas (87, 91), However, whether it can be used as a prognostic factor and therapeutic target for chordoma is currently unknown.